LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2019. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $327,000 | -44.9% | 102,606 | -26.1% | 0.00% | – |
Q1 2022 | $593,000 | -8.6% | 138,889 | -0.4% | 0.00% | – |
Q4 2021 | $649,000 | +16.1% | 139,501 | -0.4% | 0.00% | – |
Q3 2021 | $559,000 | -67.5% | 140,011 | -65.2% | 0.00% | -100.0% |
Q2 2021 | $1,720,000 | +130.6% | 401,819 | +128.5% | 0.00% | 0.0% |
Q1 2021 | $746,000 | -74.1% | 175,836 | -46.2% | 0.00% | -80.0% |
Q3 2019 | $2,878,000 | -70.4% | 327,057 | -68.9% | 0.01% | -66.7% |
Q2 2019 | $9,739,000 | +43.8% | 1,052,888 | -0.0% | 0.02% | +50.0% |
Q1 2019 | $6,773,000 | +46.5% | 1,053,303 | +114.8% | 0.01% | +42.9% |
Q4 2018 | $4,623,000 | +58.5% | 490,273 | +390.3% | 0.01% | +75.0% |
Q2 2018 | $2,917,000 | -2.0% | 100,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,978,000 | +902.7% | 100,000 | +985.3% | 0.00% | – |
Q4 2017 | $297,000 | -50.2% | 9,214 | -46.2% | 0.00% | -100.0% |
Q3 2017 | $596,000 | -12.5% | 17,140 | -55.9% | 0.00% | 0.0% |
Q4 2016 | $681,000 | +46.8% | 38,828 | +74.9% | 0.00% | 0.0% |
Q1 2016 | $464,000 | – | 22,202 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |